ALBIREO PHARMA INC - COMMON STOCK (ALBO)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COMMON STOCK
Total 13F shares
16,254,769
Share change
+5,377,807
Total reported value
$542,366,618
Put/Call ratio
669%
Price per share
$33.37
Number of holders
106
Value change
+$181,989,940
Number of buys
68
Number of sells
33

Institutional Holders of ALBIREO PHARMA INC - COMMON STOCK (ALBO) as of Q3 2020

As of 30 Sep 2020, ALBIREO PHARMA INC - COMMON STOCK (ALBO) was held by 106 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,254,769 shares. The largest 10 holders included FEDERATED HERMES, INC., PERCEPTIVE ADVISORS LLC, BlackRock Inc., Artal Group S.A., ArrowMark Colorado Holdings LLC, Cormorant Asset Management, LP, MARSHALL WACE, LLP, COWEN AND COMPANY, LLC, BAKER BROS. ADVISORS LP, and Chicago Capital, LLC. This page lists 106 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.